SXRN

舒欣瑞纳

Report date: 2025/07/02 16:48:29

Base Information

Drug NameSXRN
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursAnorexiaCachexia +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Nutai Biologics Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursAnorexiaCachexia
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A